Slideshow
Author(s):
A new study has found that an RNA-binding protein called TDP-43 could be a promising new biomarker for diagnosing amyotropic lateral sclerosis.
FDA Removes Partial Hold for Myotonic Dystrophy Agent AOC 1001
Episode 124: Therapeutic Updates and Progress in Treating Becker Muscular Dystrophy
Duchenne Gene Therapy Shows No Alteration of Cardiac Outcomes in Phase 3 EMBARK Study
Episode 122: RNA Therapeutics, Mivelsiran, and Treating Alzheimer Disease
Zilganersen Gains FDA Fast Track for Alexander Disease, a Rare Leukodystrophy
Exploring the Impact of Circadian Rhythms on Glial Function and Alzheimer Disease